Wlaschek M, Scharffetter-Kochanek K
Recent clinical trials in people in the early stages of dementia have raised the possibility that drugs that enhance GLP-1 signalling could have neuroprotective effects
Clinical evidence of the efficacy and safety of a new multi-peptide anti-aging topical eye serum
Using web-based protease cleavage site prediction tools, we show that M pro may be targeting not only GPX1, but several other selenoproteins including SELENOF and thioredoxin reductase 1, as well as glutamate-cysteine ligase, the rate-limiting enzyme for glutathione synthesis
Supporting Nerves: It maintains healthy nerves, which are essential for sharp sensations and muscle movements
Development and characterization of a novel GHR antibody antagonist, GF185